Guard Therapeutics International AB (publ) (STO:GUARD)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.500
+0.100 (7.14%)
Jul 24, 2026, 5:29 PM CET

STO:GUARD Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
---000
Revenue Growth
------
Gross Profit
000000
Operating Income
-80.98-107.2-99.91-115.07-114.92-81.9
Net Income
-80.99-108.85-96.07-113.32-112.84-82.03
Earnings Per Share
-4.07-6.04-8.62-11.26-16.01-18.50
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4149.8354.1983.74201.01188.61
Total Debt
000000
Net Cash (Debt)
4149.8354.1983.74201.01188.61
Net Cash Growth
154.69%-8.05%-35.29%-58.34%6.58%109.46%
Net Cash Per Share
2.052.764.868.3228.5242.27

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-82.35-109.35-94.75-116.05-102.14-77.59
Free Cash Flow
-82.35-109.35-94.75-116.05-102.14-77.59
Free Cash Flow Growth
------

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-11.76----